Healthcare Administrative Partners

Risk Management
Practices must comply with the Corporate Transparency Act
Healthcare Administrative Partners
A new column from Healthcare Administrative Partners discusses the impact of the Corporate Transparency Act on medical practices.
December 20, 2024
Corporate Transparency
Page 1 of 1
Top Stories
Representative longitudinal chest CT images and five-year parametric response mapping (PRM), pulmonary vascular CT reconstructions, and hyperpolarized xenon-129 (Xe-129) ventilation MRI scans from survivors of nonsevere and severe COVID-19 pneumonia. (A–F) Images in a 68-year-old male survivor of nonsevere COVID-19 pneumonia, (G–L) 62-year-old male survivor of severe COVID-19 pneumonia, and (M–R) 55-year-old male survivor of severe COVID-19 pneumonia. For each participant, the first three columns show coronal chest CT images from the acute phase (A, G, M), two-year follow-up (B, H, N), and five-year follow-up (C, I, O) (left to right). The fourth column (D, J, P) shows a coronal PRM image for each participant at five-year follow-up derived from paired inspiratory and expiratory CT scans, showing the spatial distribution of lung functional categories. Green indicates normal lung tissue, yellow indicates functional small airway disease, and red indicates emphysema. The second-to-last column shows volume-rendered small pulmonary vessel visualization (red) at five-year follow-up per participant (E, K, Q). The column on the far right (F, L, R) shows a hyperpolarized Xe-129 MRI ventilation defect percentage (VDP) map at five-year follow-up per participant. Dark blue represents high Xe-129 signal intensity, corresponding to well-ventilated lung regions, whereas red represents no Xe-129 signal intensity, corresponding to ventilation defects. At five-year follow-up, the 68-year-old survivor of nonsevere COVID-19 pneumonia (top row) showed near-complete radiologic resolution, no respiratory symptoms, and preserved pulmonary function. In contrast, the 62-year-old survivor of severe COVID-19 pneumonia (middle row) showed persistent fibrotic linear opacities without respiratory symptoms and mildly reduced pulmonary function. The 55-year-old survivor of severe COVID-19 pneumonia (bottom row) showed persistent scattered fibrotic linear opacities and focal emphysematous changes in both lungs, with dyspnea and impaired gas exchange function. The VDP values obtained from F, L, and R were 7.7%, 7.1%, and 6.3%, respectively.
CT
What are the effects of COVID-19 pneumonia after 5 years?
After five years, residual lesions persisted in 35.6% of survivors (37 of 104).
Nuclear Medicine
Molecular Imaging
USC researchers develop “plug-and-play" platform for PET tracers
Representative MRI scans for which the independently assigned imaging-derived extranodal extension (iENE) grades differed among the readers. (A) Axial and sagittal images in a 56-year-old male patient with nasopharyngeal carcinoma and cervical nodal metastases. Readers 1 and 3 interpreted the finding as a metastatic lymph node invading the left sternocleidomastoid muscle (arrow) and assessed an iENE grade of 3, whereas reader 2 assigned a grade of 2. After joint review, the radiologists reached a consensus on the absence of definite sternocleidomastoid muscle invasion, and the final iENE grade was 2. (B) Axial and sagittal images in a 52-year-old male patient with nasopharyngeal carcinoma and cervical nodal metastases. Reader 1 interpreted the findings as a single enlarged metastatic lymph node and assessed an iENE grade of 1, whereas readers 2 and 3 interpreted them as two coalescent metastatic lymph nodes (arrows) and assessed a grade of 2. After joint review, the radiologists reached a consensus on the coalescence of the two metastatic lymph nodes, and the final iENE grade was 2.
MRI
Image-based grading system estimates nasopharyngeal carcinoma severity
Astro
ASTRO 2026
ASTRO 2026 to center on translating radiotherapy data into dialogue
Free Webinar: CT Contrast Injection Reimagined
Sponsor Content
Free Webinar: CT Contrast Injection Reimagined
More in Authors
Joe Mason
August 21, 2026
Joe Mason Headshot
Brandon Bush
August 21, 2026
Brandon Bush Headshot
Phil Rackliffe
June 17, 2026
Phil Rackliffe Gehc Headshot
Kristin Seitz
June 17, 2026
Kris Seitz 2026
Philips Healthcare Informatics
June 3, 2026
Phillips
Rob Carfagno
March 23, 2026
Beatriz Dominguez Gonzalez
March 13, 2026
Beatriz Materialise
Matthew Dedman
March 12, 2026
Dedman Matthew
Peter Enever
March 11, 2026
Native Elekta 2
Charles Morris
February 25, 2026
Aiyana Amess
January 27, 2026
Kelly Brock
December 16, 2025
Kelly Brock
Page 1 of 2
Next Page